| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |